Access to anti-retroviral drugs, female in Oman
Oman: Access to anti-retroviral drugs, female was 76.0% in 2024. ◆ Volatile
Access to anti-retroviral drugs, female in Oman, 2000–2024
Source: UNAIDS estimates. Measured in %.
Analysis
The most recent figure for access to anti-retroviral drugs, female in Oman is 76.0%, measured in 2024. That is the highest value across all 25 years on record.
Compared with earlier readings it is up 2.7% on the previous year and up 46.2% over ten years.
Over the whole period, access to anti-retroviral drugs, female in Oman peaked at 76.0% in 2024 and was at its lowest, 9.0%, in 2000.
Oman ranks 64th of 141 countries on this measure, in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Access to anti-retroviral drugs, female in Oman, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 9.0% | — |
| 2001 | 11.0% | +22.2% |
| 2002 | 12.0% | +9.1% |
| 2003 | 14.0% | +16.7% |
| 2004 | 15.0% | +7.1% |
| 2005 | 17.0% | +13.3% |
| 2006 | 18.0% | +5.9% |
| 2007 | 25.0% | +38.9% |
| 2008 | 28.0% | +12.0% |
| 2009 | 34.0% | +21.4% |
| 2010 | 42.0% | +23.5% |
| 2011 | 48.0% | +14.3% |
| 2012 | 47.0% | -2.1% |
| 2013 | 53.0% | +12.8% |
| 2014 | 52.0% | -1.9% |
| 2015 | 54.0% | +3.8% |
| 2016 | 59.0% | +9.3% |
| 2017 | 63.0% | +6.8% |
| 2018 | 66.0% | +4.8% |
| 2019 | 71.0% | +7.6% |
| 2020 | 65.0% | -8.5% |
| 2021 | 70.0% | +7.7% |
| 2022 | 70.0% | +0.0% |
| 2023 | 74.0% | +5.7% |
| 2024 | 76.0% | +2.7% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 18.3% | 9.0% | 34.0% | 10 |
| 2010s | 55.5% | 42.0% | 71.0% | 10 |
| 2020s | 71.0% | 65.0% | 76.0% | 5 |
Countries ranked near Oman
More gender data for Oman
- Child population (UN estimates and projections) 1,409 (2030)
- Child population (UN estimates and projections) (0-14), annual growth 0.1678 % change on previous year (2030)
- Population 4,704 (2030)
- Working-age population (UN estimates and projections) 4,704 (2030)
- Population (UN estimates and projections), annual growth rate 1.82 % change on previous year (2030)
- Age population, age 00, female, interpolated 43,819 (2025)
- Age population, age 00, male, interpolated 45,624 (2025)
- Age population, age 01, female, interpolated 41,956 (2025)
- Age population, age 01, male, interpolated 43,673 (2025)
- Age population, age 02, female, interpolated 39,215 (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, female in Oman?
- Access to anti-retroviral drugs, female in Oman was 76.0% in 2024, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, female recorded in Oman?
- The highest recorded value was 76.0% in 2024.
- What is the lowest access to anti-retroviral drugs, female recorded in Oman?
- The lowest recorded value was 9.0% in 2000.
- How does Oman rank for access to anti-retroviral drugs, female?
- Oman ranks 64th out of 141 countries with data for 2024.
- Is access to anti-retroviral drugs, female rising or falling in Oman?
- Over the last ten years it is up 46.2%. The long-run trend across the full record is volatile.
- Where does this Oman data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, female (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.